Allergan reported to seek other partners

Share this article:

Bloomberg reports that Allergan has pursued Sanofi and Johnson & Johnson to partner up and help the company avoid being absorbed by Valeant.

Valeant's $45.7-billion bid is its second offer, and one which Bloomberg noted that Allergan has not yet responded to. According to the news service, it's not clear if Sanofi or J&J have said they are interested in the Botox maker.

Share this article:

Email Newsletters

More in Business Briefs

Imbruvica lassoes CLL indication

The FDA slapped a Breakthrough Therapy label on the CLL indication pursuit in February.

FDA asks social media "how'm I doin?"

The FDA's Center for Drug Evaluation and Research's Office of Communications wants a system that will help assess its messaging reach across the interwebs and its many forums.

Reckitt Benckiser wants out of pharma

The company plans to spin off its pharmaceutical unit.